Publicou 4 edições por ano
ISSN Imprimir: 2160-2468
ISSN On-line: 2160-2476
Rectal Cancer: What Patients Face and Express During Their Care Experience
RESUMO
In Western countries, colorectal cancer (CRC) is the third most common type of cancer in terms of incidence and mortality, after breast cancer in women and lung cancer in men. Rectal cancer (RC) comprises 30−40% of CRC cases. After the introduction of multimodal treatment and the development of the surgical techniques, long-term survival is improving. Considering the importance of the functional and anatomical complexities related to RC, the goal of treatment comprises long-term functional outcomes and monitoring of distress and quality of life (QoL) of patients. Like other cancers, symptoms at diagnosis, toxicity of treatments, and impact of surgery are different for each patient. This article describes what patients face and express during their treatment programs and what defines the care pathway that best supports their disease-related experience. Patients showed interest and appreciation for the administration of QoL questionnaires, and they reported feeling reassured by being followed by a complete and coordinated team. This efficient therapeutic alliance may result in less psychological distress for these patients.